期刊文献+

经尿道等离子电切前列腺的应用 被引量:1

Application of transurethral bipolar plasma kinetic prostatectomg
下载PDF
导出
摘要 目的:评价经尿道双极等离子体前列腺切除(TUPKP)的安全性和有效性。方法:81例良性前列腺增生(BPH)患者。采用等离子体切割技术经尿道前列腺切除,切割方法采用Alcock或Flocks法。术后随访3个月~1年,比较术后最大尿流率(Qmax)和IPSS评分恢复情况。结果:手术时间30~90分钟,切割获取前列腺组织平均50g,平均出血150ml。术后持续膀胱冲洗时间0.5~1天,留置导尿管3~5天,平均住院6天。术后3个月Qmax平均恢复至每秒24.5ml,IPSS评分由24分降至6分。结论:初步结果显示,TUPKP治疗BPH是安全可靠的,与经尿道膀胱肿瘤电切术(TURBt)比较,具有安全性高、适应证广、出血少、损伤小、恢复快等优点。 Objective:To assess the efficacy and the safety of transurethral bipolar plasma kinetic prostatectomy (TUPKP).Methods:Eighty-one patients (mean age70,with a range of 52~85 years) with benign prostatic hyperplasia(BPH) underwent TUPKP.The methods of the operation were Alcock or Flocks.After operation,the patients were followed up for 3 months to 1 year and measured for the International Prostate Symptom Score (IPSS) and maximum urinary flow rate.Results:The operative time was 30 minutes to 90 minutes. The average weight of the prostate tissue cut of in the operation was 55g. The average blood loss was 150ml. The time of postoperative continuous bladder irrigation was 0.5 day to 1 day.The catheterization time was 3 days to 5 days. Theaverage postoperative hospital stay was 6 days.The mean peak flow rate increased at least 24.5 ml/s and the IPSS decreased from 24 to 6 at 3 months.Conclusion:The preliminary results with TUPKP suggest that it is a useful and safe endoscopic device. It appears to be an effective treatment for BPH. This pilot series permits a comparative study with TURP to assess the benefits for patients and the health care system.
作者 张淑健
出处 《现代医药卫生》 2008年第5期645-646,共2页 Journal of Modern Medicine & Health
  • 相关文献

参考文献3

二级参考文献13

  • 1陈建华,盛申耀,凌春华,朱荣旋,蒋鹤鸣.经尿道电切前列腺综合征九例报告[J].临床泌尿外科杂志,1994,9(4):198-199. 被引量:22
  • 2叶敏,张良,陈建华,孔良,王伟明,马邦一,蒋鹤鸣.经尿道前列腺电汽化术治疗前列腺增生症[J].中华泌尿外科杂志,1997,18(7):417-420. 被引量:190
  • 3[1]Mcbust W K,Holtgrewe H L,Cockett A T K,et al.Transurethral prostatectomy; Immediate and postoper ative complications. Axooperative study of thirteen par ticipating institution evaluating 3885 patients . J Urol,1989,141: 243- 247.
  • 4[2]Evans J, Singer M,Coppinger S, et al. Cardiovascular performance and core temperature during transurethral prostatectomy. J Urol, 1994,152,2025 2028.
  • 5[3]Freedman M, van Molen S W, Makings E. Blood loss measurement during transurethral resection of the prostate gland. Br J Uro1,1985,57:311-314.
  • 6[4]Ekengren J ,Hahn R G. Blood loss during transurethral resection of the prostate as measured by the hemochrome photometer. J Urol, 1993,42: 501 - 505.
  • 7[5]Narayan P,Tewari A, Croker, et al. Factors affecting sizes and configuration of electrovaporization lesions ing th the prostate. J Uro1,1996,47:679-683.
  • 8[6]Elengren J, Hmhn R G. Complications during transurethral aporization. Urology, 1996,48: 424- 427.
  • 9[7]Henry B,Barre P. Electro-vaporisation of the prostate with the gyrus device. Eur Urol, 2000,37 (Suppl 2): 1 -175.
  • 10[8]Virdi,Faiyaz K, Ponnambalam Chandrasekar, et al. A prospectiverandomised study between transurethral va porisation using plasmakinetic energy. J Urol , 163(Suppl) :268-271.

共引文献709

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部